MusB Research

Menu

+1- 813-419-0781

MusB Research Launches New Website to Expand State-of-the-Art Research Services

Tampa, FL – MusB Research, a pioneering company in the field of nutraceutical, diet, and pharmaceutical research, is proud to announce the launch of its new website. With over 20 years of research experience, MusB Research is dedicated to providing state-of-the-art services to clients looking to substantiate their product claims in areas such as microbiome health, aging, probiotics, leaky gut, toxicity, gut health, brain health, muscle health, obesity, diabetes, and bioavailability.

The new website offers a comprehensive overview of MusB Research’s services, showcasing their expertise in developing innovative solutions for the nutraceutical, dietary, and pharmaceutical industries. The website’s user-friendly design ensures easy navigation for clients seeking detailed information about how MusB Research can help them achieve market dominance through scientifically validated evidence.

“We are excited to launch our new website and expand our reach to a broader audience,” said Dr. Shalini Jain, Founder and CEO of MusB Research. “Our mission is to support our clients with cutting-edge research that substantiates their product claims and drives innovation in the competitive health market. Our new online platform reflects our commitment to excellence and our dedication to helping clients succeed.”

MusB Research’s advanced models and assays provide valuable insights into the efficacy and safety of products, enabling clients to develop evidence-based products that stand out in the market. With a focus on areas such as aging, microbiome health, and metabolic diseases, MusB Research leverages its extensive expertise to deliver reliable and impactful results.

Visit the new MusB Research website at www.musbresearch.com to learn more about their services and how they can help you substantiate your product claims with robust scientific data. Contact MusB Research today to get started on your project and take your products to the next level.

MusB Research Launches to Offer Cutting-Edge Research Services for Nutraceutical, Diet, and Pharma Companies

Tampa, FL – [Date] – MusB Research, a pioneering venture in scientific research, is excited to announce its official launch. The company is set to provide state-of-the-art research services aimed at helping nutraceutical, dietary, and pharmaceutical companies develop substantiation for their products.

MusB Research leverages years of expertise in the fields of microbiome, aging, probiotics, leaky gut, toxicity, gut health, brain health, muscle health, obesity and diabetes, and bioavailability. The company’s comprehensive services include advanced assays, animal models, and clinical studies designed to validate product claims with robust scientific evidence.

“At MusB Research, our mission is to drive innovation and success for our clients by offering unparalleled research services,” said Dr. Hariom Yadav, founder and CEO of MusB Research. “We understand the critical importance of scientifically validated evidence in today’s competitive market. Our cutting-edge research capabilities will enable our clients to substantiate their product claims effectively and stand out in the marketplace.”

MusB Research’s offerings include:

  • Microbiome and Gut Health: Advanced testing and analysis to understand the impact of products on gut microbiota and overall gut health.
  • Probiotics Development: Specialized assays to develop and validate the efficacy of probiotic strains.
  • Aging and Longevity: Research focused on anti-aging properties and interventions to promote healthy aging.
  • Leaky Gut and Toxicity: Comprehensive studies to assess product safety and efficacy in preventing or mitigating leaky gut syndrome and other toxicological concerns.
  • Brain and Muscle Health: In-depth analysis of product effects on cognitive function, neuroprotection, and muscle health.
  • Obesity and Diabetes: Evaluation of compounds for their potential to manage weight and improve metabolic health.
  • Bioavailability: Studies to determine the absorption and efficacy of bioactive compounds in various products.

MusB Research is committed to providing clients with detailed reporting, future recommendations, and consulting services to maximize their product’s market potential. By partnering with MusB Research, companies can ensure their products are backed by rigorous scientific data, enhancing credibility and consumer trust.

For more information about MusB Research and its services, please visit [website link] or contact [contact information].

Media Contact:

Dr. Hariom Yadav
Founder and CEO, MusB Research
[Email Address]
[Phone Number]

About MusB Research: MusB Research is a leading scientific research company specializing in providing comprehensive research services for nutraceutical, dietary, and pharmaceutical companies. With a focus on microbiome, aging, probiotics, leaky gut, toxicity, gut health, brain health, muscle health, obesity and diabetes, and bioavailability, MusB Research aims to drive innovation and success through scientifically validated evidence.

MusB Research Enters Market with Over 20 Years of Expertise to Cater to a Specialized Niche in Nutraceutical, Diet, and Pharma Industries

Tampa, FL – [Date] – MusB Research is proud to announce its launch, bringing over 20 years of extensive research experience to the nutraceutical, dietary, and pharmaceutical industries. The company aims to cater to a specialized niche, offering cutting-edge research services to help clients substantiate their product claims and gain a competitive edge in the market.

MusB Research is founded on a legacy of scientific excellence, focusing on areas such as microbiome, aging, probiotics, leaky gut, toxicity, gut health, brain health, muscle health, obesity and diabetes, and bioavailability. The company’s state-of-the-art research capabilities are designed to provide robust, evidence-based validation for a wide range of products.

“Our team at MusB Research has a deep understanding of the scientific intricacies required to support the claims of nutraceutical, dietary, and pharmaceutical products,” said Dr. Hariom Yadav, founder and CEO of MusB Research. “With over two decades of research experience, we are uniquely positioned to offer unparalleled services that help our clients navigate the complexities of product substantiation and succeed in a competitive market.”

Key Services Offered by MusB Research:

  • Microbiome and Gut Health: Advanced testing and analysis to explore the effects of products on gut microbiota and overall gut health.
  • Probiotics Development: Expertise in developing and validating the efficacy of probiotic strains.
  • Aging and Longevity: Focused research on anti-aging properties and interventions for promoting healthy aging.
  • Leaky Gut and Toxicity: Comprehensive assessments to determine product safety and efficacy in addressing leaky gut syndrome and toxicological concerns.
  • Brain and Muscle Health: In-depth analysis of the impact of products on cognitive function, neuroprotection, and muscle health.
  • Obesity and Diabetes: Evaluation of compounds for their potential to manage weight and improve metabolic health.
  • Bioavailability: Studies to assess the absorption and efficacy of bioactive compounds in various products.

MusB Research’s commitment to scientific rigor and innovation is reflected in its detailed reporting, future recommendations, and consulting services, all aimed at maximizing the market potential of client products. By partnering with MusB Research, companies can ensure their products are backed by robust scientific data, enhancing credibility and consumer trust.

For more information about MusB Research and its specialized services, please visit [website link] or contact [contact information].

Media Contact:

Dr. Hariom Yadav
Founder and CEO, MusB Research
[Email Address]
[Phone Number]

About MusB Research: MusB Research is a pioneering scientific research company dedicated to providing comprehensive research services for the nutraceutical, dietary, and pharmaceutical industries. With over 20 years of research experience, MusB Research specializes in microbiome, aging, probiotics, leaky gut, toxicity, gut health, brain health, muscle health, obesity and diabetes, and bioavailability. The company’s mission is to drive innovation and success through scientifically validated evidence, helping clients substantiate their product claims and achieve market dominance.

PublicationsA mechanism by which gut microbiota elevates permeability and inflammation in obese/diabetic mice and human gut

Abstract

Objective Ample evidence exists for the role of abnormal gut microbiota composition and increased gut permeability (‘leaky gut’) in chronic inflammation that commonly co-occurs in the gut in both obesity and diabetes, yet the detailed mechanisms involved in this process have remained elusive.

Design In this study, we substantiate the causal role of the gut microbiota by use of faecal conditioned media along with faecal microbiota transplantation. Using untargeted and comprehensive approaches, we discovered the mechanism by which the obese microbiota instigates gut permeability, inflammation and abnormalities in glucose metabolism.

Results We demonstrated that the reduced capacity of the microbiota from both obese mice and humans to metabolise ethanolamine results in ethanolamine accumulation in the gut, accounting for induction of intestinal permeability. Elevated ethanolamine increased the expression of microRNA-miR-101a-3p by enhancing ARID3a binding on the miR promoter. Increased miR-101a-3p decreased the stability of zona occludens-1 (Zo1) mRNA, which in turn, weakened intestinal barriers and induced gut permeability, inflammation and abnormalities in glucose metabolism. Importantly, restoring ethanolamine-metabolising activity in gut microbiota using a novel probiotic therapy reduced elevated gut permeability, inflammation and abnormalities in glucose metabolism by correcting the ARID3a/miR-101a/Zo1 axis.

Conclusion Overall, we discovered that the reduced capacity of obese microbiota to metabolise ethanolamine instigates gut permeability, inflammation and glucose metabolic dysfunctions, and restoring ethanolamine-metabolising capacity by a novel probiotic therapy reverses these abnormalities.

modal close image